Žabljak
Pretežno oblačno
17.4 °C
Pljevlja
Oblačno
21.7 °C
Herceg Novi
Pretežno oblačno
27.4 °C
Nikšić
Pretežno oblačno
22.8 °C
Cetinje
Pretežno oblačno
24.4 °C
Bar
Pretežno oblačno
28.5 °C
Podgorica
Umjereno oblačno
28.5 °C
Ulcinj
Pretežno oblačno
26.7 °C
Kolašin
Umjereno oblačno
20.4 °C

We use cookies and google analytics tool to optimize the delivery of digital advertising to you. If you decline personalization of ads you will still see digital advertisements, but they will not be as relevant to you. We never collect sensitive information, and do not sell any of the data we collect. Under the GDPR regulations browser cookies are now considered sudo-anonymized personal data and since we use cookies to deliver relevant advertisements to you we would like to get your permission to do so.

I don't want my data to be used anymore for analytic purposes.

World

10. 07. 2020. 16:56   >>  16:56 0

IN RUSSIA

Vaccine trials are entering their final phase

The Russian Ministry of Defense and the National Research Center for Epidemiology and Microbiology Gamaleya have started the final phase of the clinical trial of the coronavirus vaccine.

According to the announcement of the Ministry of Defense, the testing of the first group of volunteers used for testing safety and tolerance of the vaccine, will end on July 15.

Another group of volunteers who are being tested for efficacy and immunogenicity of the vaccine will be injected with another ingredient in the coronavirus vaccine. 

In the second phase, the goal is to strengthen the immune system and prolong the effect of the vaccine.

It was added that the volunteers feel good, that they have no problems or side effects. The first group will be discharged from the Burdenko military hospital after passing the final tests, reported TAS S.

Komentari 0

ostavi komentar

Ostavi komentar

Pravila komentarisanja sadržaja Portala RTCG
Poštujući načelo demokratičnosti, kao i pravo građana da slobodno i kritički iznose mišljenje o pojavama, procesima, događajima i ličnostima, u cilju razvijanja kulture javnog dijaloga, na Portalu nijesu dozvoljeni komentari koji vrijeđaju dostojanstvo ličnosti ili sadrže prijetnje, govor mržnje, neprovjerene optužbe, kao i rasističke poruke. Nijesu dozvoljeni ni komentari kojima se narušava nacionalna, vjerska i rodna ravnopravnost ili podstiče mržnja prema LGBT populaciji. Neće biti objavljeni ni komentari pisani velikim slovima i obimni "copy/paste" sadrzaji knjiga i publikacija.Zadržavamo pravo kraćenja komentara.

Da biste komentarisali vijesti pod vašim imenom

Ulogujte se

Novo